首页> 外文OA文献 >A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL

【2h】

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL

机译：venetoclax单独或与R / R ClL中的抗CD20单克隆抗体组合的回顾性比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Anthony R. Mato; Lindsey E. Roeker; Toby A. Eyre; Chadi Nabhan; Nicole Lamanna; Brian T. Hill; Danielle M. Brander; Paul M. Barr; Frederick Lansigan; Bruce D. Cheson; Arun K. Singavi; Maryam Sarraf Yazdy; Nirav N. Shah; John N. Allan; Erica B. Bhavsar; Joanna Rhodes; Kaitlin Kennard; Stephen J. Schuster; AnnaLynn M. Williams; Alan P. Skarbnik; Andre H. Goy; Julie M. Goodfriend; Colleen Dorsey; Catherine C. Coombs; Hande Tuncer; Chaitra S. Ujjani; Ryan Jacobs; Allison M. Winter; John M. Pagel; Neil Bailey; Anna Schuh; Mazyar Shadman; Andrea Sitlinger; Hanna Weissbrot; Sivraj Muralikrishnan; Andrew Zelenetz; Amy A. Kirkwood; Christopher P. Fox;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Real-life retrospective comparison of chlorambucil plus anti-CD20 antibody versus ibrutinib alone as frontline treatment for unfit CLL/SLL [J] . Loscertales Javier, Delgado Julio, Carla Oliveira Ana, Leukemia and lymphoma . 2020,第S1期

机译：氯苯胺Plus抗CD20抗体与Ibrutinib的实际回顾性比较作为Frontline治疗，用于不适合CLL / SLL
2. BTK inhibitors and anti-CD20 monoclonal antibodies for treatment-na?ve elderly patients with CLL [J] . Andrew Rogers, Jennifer A. Woyach Therapeutic advances in hematology. . 2020,第12期

机译：BTK抑制剂和抗CD20单克隆抗体用于治疗 - Na've老年CLL患者
3. CHANGES IN SERUM COMPLEMENT ACTIVITY DURING ANTI-CD20 AND ANTI-CD52 MONOCLONAL ANTIBODY THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) [J] . Stasilojc Grzegorz, Felberg Anna, Taszner Michal, Molecular Immunology . 2019,第期

机译：慢性淋巴细胞白血病患者抗CD20和抗CD52单克隆抗体治疗期间血清补体活性的变化（CLL）
4. 188Re-labeled anti-CD20 monoclonal antibody: Labeling and quality controlstudies [C] . R.Leyva Monta?a, I.Hernández González, M.Zamora Barrabí, Trends in Radiopharmaceuticals(ISTR-2005) . 2007

机译：188重新标记的抗CD20单克隆抗体：标记和质量控制研究
5. Molecular Characterization of a Novel, Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus [D] . Pal, Pankaj 2015

机译：一种针对基孔肯雅病毒的新型高度保护性组合单克隆抗体疗法的分子表征
6. A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL [O] . Anthony R. Mato, Lindsey E. Roeker, Toby A. Eyre, 2019

机译：在R / R CLL中单独或与抗CD20单克隆抗体联合使用venetoclax的回顾性比较
7. Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin’s Lymphoma [O] . Rhona Stein, Zhengxing Qu, Susan Chen, 2004

机译：新的人源化抗CD20单克隆抗体，IMPRU-106的表征及其与人源化抗CD22抗体，ePRATUZIMAB的用途，用于非霍奇金淋巴瘤的治疗

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL

著录项

引文网络

相似文献

相关主题

期刊订阅